Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
0.8101
-0.1549 (-16.05%)
At close: Nov 13, 2026, 4:00 PM EST
0.8354
+0.0253 (3.12%)
After-hours: Nov 13, 2026, 7:30 PM EST
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $105.15 million as of November 13, 2026. It is the 24,621st most valuable company in the world and the 4,005th biggest in the United States. Its market cap has decreased by 87.21% in one year.
Market Cap
105.15M
Enterprise Value
148.34M
1-Year Change
-87.21%
Global Rank
Country Rank
#4,005 United States
Category
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $105.15M, a decrease of -91.49%. That is a compound annual growth rate of -26.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 105.15M | -84.00% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 207.66M |
| ADC Therapeutics | 198.33M |
| Anika Therapeutics | 184.99M |
| Akebia Therapeutics | 138.28M |
| Journey Medical | 123.91M |
| Cardiol Therapeutics | 120.45M |
| Glass House Brands | 117.80M |
| Organigram Global | 117.69M |